Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated levels of tumor necrosis factor alpha in plasma.
about
Macrophages in rheumatoid arthritisThe glutathione defense system in the pathogenesis of rheumatoid arthritis.Effect of dietary fats on oxidative-antioxidative status of blood in ratsImpaired neutrophil directional chemotactic accuracy in chronic periodontitis patients.Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis.The role of antioxidants in models of inflammation: emphasis on L-arginine and arachidonic acid metabolism.Metabolic regulation of T lymphocytes.Influence of Insulin Resistance and TNF-α on the Inflammatory Process, Oxidative Stress, and Disease Activity in Patients with Rheumatoid Arthritis.Inducible hydrogen sulfide synthesis in chondrocytes and mesenchymal progenitor cells: is H2S a novel cytoprotective mediator in the inflamed joint?Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis.NF-kappaB-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: potential role in rheumatoid arthritis.Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis.Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment.Combination therapy with metformin and coenzyme Q10 in murine experimental autoimmune arthritis.Ten weeks of high-intensity interval walk training is associated with reduced disease activity and improved innate immune function in older adults with rheumatoid arthritis: a pilot study.
P2860
Q24806949-2073FED6-D2B8-4438-B24E-BBF7B43BE198Q31948214-EB9E2EB2-CEDC-43A6-AD7A-AECA2C0109C3Q33983542-429E89F0-3D0F-4967-B78F-737823FABC07Q35120207-A6E9D045-DD46-4007-BF92-6F976CFBB9F4Q35552814-B43EEB8B-5FA0-47AD-9532-2BB7D2E04502Q36301668-9315A2F4-6F83-4291-AC40-9D6FBA622A8AQ36711431-A2D5B1AE-342B-42BC-AF59-3D86A25211FFQ37000208-D1323308-F4D4-4092-B9D0-38FA4C02B3CCQ37294661-C4F438A7-2608-4948-9429-2ACAE69680C5Q39830600-43E6B07C-C27A-4EDF-80CB-0A165AFFC8A9Q44378763-50649568-0D14-4E90-9BF3-662202353666Q50860607-D6C18365-C512-436C-9081-531C9BD0E58EQ51045110-3E9A0B9D-5433-40C7-8606-C9641A984737Q53180498-039A7020-48B8-4BDF-AD9B-EA25D151DFF6Q55285124-2EDD403D-BC49-43F8-9013-AA6CC5EB6CE5
P2860
Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated levels of tumor necrosis factor alpha in plasma.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Enhanced mitochondrial radical ...... crosis factor alpha in plasma.
@en
Enhanced mitochondrial radical ...... crosis factor alpha in plasma.
@nl
type
label
Enhanced mitochondrial radical ...... crosis factor alpha in plasma.
@en
Enhanced mitochondrial radical ...... crosis factor alpha in plasma.
@nl
prefLabel
Enhanced mitochondrial radical ...... crosis factor alpha in plasma.
@en
Enhanced mitochondrial radical ...... crosis factor alpha in plasma.
@nl
P2093
P2860
P1476
Enhanced mitochondrial radical ...... crosis factor alpha in plasma.
@en
P2093
P2860
P304
P356
10.3109/10715769609149921
P577
1996-08-01T00:00:00Z